Dr. Lustig is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
TRC 2 West
3400 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-662-2428Fax+1 215-349-5445
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Radiation Oncology, 1973 - 1976
- New York Medical College (Metropolitan)Residency, Internal Medicine, 1970 - 1971
- Hoboken University Medical CenterInternship, Internal Medicine, 1969 - 1970
- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1969
Certifications & Licensure
- NJ State Medical License 1976 - 2025
- PA State Medical License 1973 - 2024
- NC State Medical License 2020 - 2022
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme Start of enrollment: 2005 Oct 01
- Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas Start of enrollment: 2009 Dec 17
- Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study Start of enrollment: 2010 Sep 01
Publications & Presentations
PubMed
- Machine Learning-based Prognostic Subgrouping of Glioblastoma: A Multi-center Study.Hamed Akbari, Spyridon Bakas, Chiharu Sako, Anahita Fathi Kazerooni, Javier Villanueva-Meyer
Neuro-Oncology. 2024-12-12 - 1 citationsA Prospective Phase I/II Clinical Trial of High-Dose Proton Therapy for Chordomas and Chondrosarcomas.Sana S Dastgheyb, Alexandra D Dreyfuss, Michael J LaRiviere, Jahan J Mohiuddin, Brian C Baumann
Advances in Radiation Oncology. 2024-05-01 - 36 citationsRepeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial.Stephen J Bagley, Zev A Binder, Lamia Lamrani, Eliana Marinari, Arati S Desai
Nature Cancer. 2024-03-01
Press Mentions
- Patient Empowerment Platform "Health Storylines" from Self Care Catalysts Is Being Studied at Penn's Roberts Proton Therapy CenterSeptember 21st, 2016
Professional Memberships
- Society of Neuro-OncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: